stp705
Nucleic acidexperimental
Clinical trial activity
9 trials · 5 clinical orgs · 0 marketing orgs
Phase 1
6
Phase 2
7
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2016 (NCT02956317)
Timeline
Indications
Mechanism of action
- Cyclooxygenase-2INHIBITOR
PTGS2 inhibitor
Chemistry & pharmacology
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Also known as
- stp705
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05196373 | Phase 1/Phase 2 (Phase 2) | Jun 30, 2023 | Sirnaomics |
| NCT05422378 | Phase 1 | Aug 1, 2022 | Sirnaomics |
| NCT05421013 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2022 | Sirnaomics |
| NCT04844983 | Phase 2 | May 18, 2021 | Sirnaomics |
| NCT04844840 | Phase 2 | Apr 29, 2021 | Lupin, Sirnaomics |
| NCT04676633 | Phase 1 | Mar 1, 2021 | Sirnaomics, Translational Drug Development |
| NCT04669808 | Phase 2 | Dec 16, 2020 | Amarex Clinical Research, Sirnaomics |
| NCT04293679 | Phase 1/Phase 2 (Phase 2) | May 21, 2019 | Amarex Clinical Research, Center for Clinical and Cosmetic Research, Sirnaomics |
| NCT02956317 | Phase 1/Phase 2 (Phase 2) | Nov 1, 2016 | Sirnaomics |
Showing 9 of 9 trials
Page 1 / 1
Organizations
Research & Development (5)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sirnaomics | For profit | 9 | 9 | 2 | 2016 |
| Amarex Clinical Research | For profit | 2 | 0 | 1 | 2019 |
| Center for Clinical and Cosmetic Research | For profit | 1 | 0 | 1 | 2019 |
| Lupin | For profit | 1 | 0 | 1 | 2021 |
| Translational Drug Development | For profit | 1 | 0 | 1 | 2021 |
5 organizations
Page 1 / 1